[HTML][HTML] Transporter‑mediated drug‑drug interactions involving poly (ADP‑ribose) polymerase inhibitors

D Zhao, X Long, J Wang - Oncology Letters, 2023 - spandidos-publications.com
Poly (ADP ribose) polymerase (PARP) inhibitors are novel targeted anticancer agents that
have been widely used in patients with cancer, particularly in patients with breast‑related …

[HTML][HTML] Interplay of OATP1A/1B/2B1 uptake transporters and ABCB1 and ABCG2 efflux transporters in the handling of bilirubin and drugs

W Li, RW Sparidans, Y Wang, MLF Martins… - Biomedicine & …, 2024 - Elsevier
Transmembrane drug transporters can be important determinants of the pharmacokinetics,
efficacy, and safety profiles of drugs. To investigate the potential cooperative and/or …

An Isolated Perfused Rat Liver Model: Simultaneous LC-MS Quantification of Pitavastatin, Coproporphyrin I, and Coproporphyrin III Levels in the Rat Liver and Bile

N Izat, O Kaplan, M Çelebier, S Sahin - ACS omega, 2024 - ACS Publications
The isolated perfused rat liver (IPRL) model provides a mechanistic understanding of the
organic-anion-transporting polypeptide (OATP/Oatp)-mediated pharmacokinetics in the …

Inhibition of canalicular and sinusoidal taurocholate efflux by cholestatic drugs in human hepatoma HepaRG cells

M Le Vée, A Moreau, E Jouan… - … & Drug Disposition, 2022 - Wiley Online Library
HepaRG cells are highly‐differentiated human hepatoma cells, which are increasingly
recognized as a convenient cellular model for in vitro evaluation of hepatic metabolism …

Modeling the Pathogenesis of Drug-Induced Liver Injury with Organoids and Microfluidic Devices

C Zhang - 2023 - deepblue.lib.umich.edu
Drug-induced liver injury (DILI) is a critical concern in modern medicine, encompassing a
broad spectrum of liver-related abnormalities caused by various pharmaceutical …